Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.

Agentic AI could reshape drug development. In this interview, Dr. Claudio D’Ambrosio discusses how agentic AI can identify novel drug compounds, improve trial design, and reduce operational ...

Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

Therapeutic developers are increasingly rebuilding their workflows around AI to bring drugs to patients faster.

DNA-encoded libraries have numerous advantages over traditional screening methods, including easy identification of compounds and the large quantity of compounds that can be screened simultaneously.

Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...

According to data published by Precedence Research, Generative AI is transforming the life science sector, driving innovation in drug discovery, clinical trials, and manufacturing, while reducing ...

Karthik Sankaranarayanan trained in two quite different scientific subfields as a graduate student and as a postdoctoral ...

Researchers from the Massachusetts Institute of Technology (MIT) Jameel Clinic for Machine Learning in Health have announced the open-source release of Boltz-2, which now predicts molecular binding ...

How innovative technologies like AI and gene editing are advancing rare disease drug discovery and development.

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL), ahead of the American Association for Cancer Research® (AACR) Annual Meeting in Chicago, IL, has ...